Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study

Background: Abnormalities in calcium, phosphorous and parathyroid hormone (PTH) metabolisms are common in dialysis patients. Reaching target levels for these serologic factors and calcium × phosphorous products is recommended to minimize cardiovascular events. Objectives: The aim of this study was t...

Full description

Bibliographic Details
Main Author: Mitra Naseri
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2017-10-01
Series:Journal of Nephropathology
Subjects:
Online Access:https://nephropathol.com/PDF/jnp-6-282.pdf
_version_ 1797828017311973376
author Mitra Naseri
author_facet Mitra Naseri
author_sort Mitra Naseri
collection DOAJ
description Background: Abnormalities in calcium, phosphorous and parathyroid hormone (PTH) metabolisms are common in dialysis patients. Reaching target levels for these serologic factors and calcium × phosphorous products is recommended to minimize cardiovascular events. Objectives: The aim of this study was to examine calcium, phosphorous and intact PTH (iPTH) abnormalities in a group of dialysis patients. Patients and Methods: Bone minerals status and iPTH levels were assessed in 46 dialysis patients aged 19-300 (165.2 ± 75.73) months. Low and high Ca dialysate solutions routinely were used for hemodialysis (63%) and peritoneal dialysis (30.4%) patients respectively. Comparisons between groups were performed with considering age (≤5, 6-10, and > 10 years), gender and modality of dialysis. Results: Serum calcium and corrected calcium levels were significantly higher in peritoneal dialysis (PD) patients. Hypoparathyroidism was the most frequent iPTH abnormality (58.7%). It was more prevalent in males. Hyperparathyroidism was more frequent in females. Conclusions: We found that hypoparathyroidism is the most prevalent PTH abnormality. We also noted that patients on peritoneal dialysis are more prone to develop this form of PTH abnormality. We found that phosphate control is better in peritoneal dialysis vs. hemodialysis cases.
first_indexed 2024-04-09T12:57:43Z
format Article
id doaj.art-f975ec97423b4813ac1aefd8f3e4ad29
institution Directory Open Access Journal
issn 2251-8363
2251-8819
language English
last_indexed 2024-04-09T12:57:43Z
publishDate 2017-10-01
publisher Society of Diabetic Nephropathy Prevention
record_format Article
series Journal of Nephropathology
spelling doaj.art-f975ec97423b4813ac1aefd8f3e4ad292023-05-13T11:31:11ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropathology2251-83632251-88192017-10-016428228910.15171/jnp.2017.47jnp-20170615095200Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center studyMitra Naseri0Department of Pediatric Nephrology, Mashhad University of Medical Sciences, Mashhad, IranBackground: Abnormalities in calcium, phosphorous and parathyroid hormone (PTH) metabolisms are common in dialysis patients. Reaching target levels for these serologic factors and calcium × phosphorous products is recommended to minimize cardiovascular events. Objectives: The aim of this study was to examine calcium, phosphorous and intact PTH (iPTH) abnormalities in a group of dialysis patients. Patients and Methods: Bone minerals status and iPTH levels were assessed in 46 dialysis patients aged 19-300 (165.2 ± 75.73) months. Low and high Ca dialysate solutions routinely were used for hemodialysis (63%) and peritoneal dialysis (30.4%) patients respectively. Comparisons between groups were performed with considering age (≤5, 6-10, and > 10 years), gender and modality of dialysis. Results: Serum calcium and corrected calcium levels were significantly higher in peritoneal dialysis (PD) patients. Hypoparathyroidism was the most frequent iPTH abnormality (58.7%). It was more prevalent in males. Hyperparathyroidism was more frequent in females. Conclusions: We found that hypoparathyroidism is the most prevalent PTH abnormality. We also noted that patients on peritoneal dialysis are more prone to develop this form of PTH abnormality. We found that phosphate control is better in peritoneal dialysis vs. hemodialysis cases.https://nephropathol.com/PDF/jnp-6-282.pdfckdhemodialysisperitoneal dialysispthparathormone
spellingShingle Mitra Naseri
Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
Journal of Nephropathology
ckd
hemodialysis
peritoneal dialysis
pth
parathormone
title Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
title_full Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
title_fullStr Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
title_full_unstemmed Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
title_short Hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients; a single center study
title_sort hypoparathyroidism versus hyperparathyroidism in pediatric dialysis patients a single center study
topic ckd
hemodialysis
peritoneal dialysis
pth
parathormone
url https://nephropathol.com/PDF/jnp-6-282.pdf
work_keys_str_mv AT mitranaseri hypoparathyroidismversushyperparathyroidisminpediatricdialysispatientsasinglecenterstudy